Blue Square Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,179
Closed -$610K 84
2021
Q4
$610K Sell
12,179
-3,713
-23% -$184K 0.38% 61
2021
Q3
$766K Buy
15,892
+4,860
+44% +$247K 0.48% 60
2021
Q2
$581K Buy
11,032
+505
+5% +$26.4K 0.36% 66
2021
Q1
$521K Buy
10,527
+547
+5% +$26.3K 0.33% 68
2020
Q4
$485K Buy
9,980
+2,448
+33% +$121K 0.32% 70
2020
Q3
$378K Buy
7,532
+4,548
+152% +$234K 0.26% 65
2020
Q2
$152K Sell
2,984
-4,186
-58% -$203K 0.1% 76
2020
Q1
$313K Sell
7,170
-2,101
-23% -$101K 0.29% 58
2019
Q4
$465K Buy
9,271
+4,344
+88% +$204K 0.36% 73
2019
Q3
$228K Buy
+4,927
New +$212K 0.18% 73

Other funds holding SNY

Blue Square Asset Management's SNY Position: Q1 2022 in Review

Blue Square Asset Management sold out of Sanofi (SNY) in Q1 2022, closing a stake of 12,179 shares — an estimated $610K sold.

Blue Square Asset Management first reported a position in SNY in Q3 2019 and held it in 10 quarters. The position peaked at $766K in Q3 2021. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

  • Blue Square Asset Management reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
  • Blue Square Asset Management sold 12,179 Sanofi shares in Q1 2022, an estimated $610K.
  • Blue Square Asset Management first reported a position in Sanofi in Q3 2019 and held it in 10 quarters.
  • Blue Square Asset Management's Sanofi position peaked at $766K in Q3 2021.
  • 623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Blue Square Asset Management's 13F filing for Q1 2022, filed 2 May 2022.